Evidence map›Paper›PMID 30223874›Full record

ArticleTrials2018

Evaluating the integration of HIV self-testing into low-resource health systems: study protocol for a cluster-randomized control trial from EQUIP Innovations.

Kathryn Dovel, Frackson Shaba, Mike Nyirenda, O Agatha Offorjebe, Kelvin Balakasi, Khumbo Phiri, Brooke Nichols, Chi-Hong Tseng, Ashley Bardon, Khumbo Ngona and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03271307 (Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners), which is not on this map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03271307 nacompletednot on this map

Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners

TypeinterventionalSponsorUniversity of California, Los AngelesRan2017 to 2019Enrolled6,369ConditionsHIV InfectionsArmsOptimized PITC, Facility HIVST, Index HIVST
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kathryn DovelDivision of Infectious Diseases, Department of Medicine, University of California Los Angeles, 10833 Le Conte Ave, 37-121 CHS, Los Angeles, CA, 90095, USA. kdovel@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-5622-3401
Frackson ShabaPartners in Hope, PO Box 302, Lilongwe, Malawi.
Mike NyirendaPartners in Hope, PO Box 302, Lilongwe, Malawi.
O Agatha OfforjebeDavid Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, 37-121 CHS, Los Angeles, CA, 90095, USA.
Kelvin BalakasiPartners in Hope, PO Box 302, Lilongwe, Malawi.
Khumbo PhiriPartners in Hope, PO Box 302, Lilongwe, Malawi.
Brooke NicholsHERO, Boston University, Postnet Suite 212, Private Bag X2600, Houghton, 2041, South Africa.
Chi-Hong TsengDivision of General Internal Medicine and Health Services Research, Department of Medicine, University of California Los Angeles, 911 Broxton Ave, 3rd Floor, Los Angeles, CA, 90024, USA.
Ashley BardonDivision of Infectious Diseases, Department of Medicine, University of California Los Angeles, 10833 Le Conte Ave, 37-121 CHS, Los Angeles, CA, 90095, USA.
Khumbo NgonaMalawian Ministry of Health, Department of HIV/AIDS, Lilongwe, Malawi.
Risa HoffmanDivision of Infectious Diseases, Department of Medicine, University of California Los Angeles, 10833 Le Conte Ave, 37-121 CHS, Los Angeles, CA, 90095, USA.

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
University of California Launching Future Leaders in Global Health Research Training ProgramD43TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIG R COHEN, Sung-Jae Lee · 2017 to 2026
$14.7M
Postdoctoral Training in Global AIDS Prevention ResearchT32MH080634 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JESSE LAWTON CLARK, Pamina Mae Gorbach · 2007 to 2026
$6.4M
FIC NIH HHS D43 TW009343National Institute of Mental Health T32MH080634-10NCATS NIH HHS UL1 TR001881NIAID NIH HHS P30 AI028697NIMH NIH HHS T32 MH080634UCLA Center for AIDS Research AI028697United States Agency for International Development AID-OAA-A-15-00070
6 · The paper itself

Abstract

backgroundThroughout sub-Saharan Africa HIV-testing rates remain low. Barriers to testing, such as inconvenient service hours and long wait times, lack of privacy, and fear of unwanted disclosure, continue to impede service utilization. HIV self-testing (HIVST) is one strategy that addresses these barriers and has been shown to increase use of HIV-testing when distributed through community-based settings. However, the scalability of HIVST is limited because it has yet to be fully integrated into existing health systems and routine care. To address this gap, we designed a study to test the effect of offering HIVST to routine outpatient department (OPD) clients on uptake of HIV-testing as compared to standard of care and optimized standard of care. METHODS/

designThis is a non-blinded, multi-site, cluster-randomized control trial. The health facility is the unit of randomization (cluster). Fifteen facilities were randomized to one of three arms: (1) Standard of care using routine provider-initiated testing and counseling (PITC); (2) Optimized standard of care using optimized PITC defined by additional training, job aids, and monitoring of PITC strategies with OPD providers and support staff; and (3) HIVST defined by HIVST demonstrations for OPD clients, HIVST kit distribution, and private spaces for HIVST kit use and/or interpretation. The primary outcome is the proportion of OPD clients tested for HIV on the day that they accessed OPD services. Secondary outcome measures are the proportion of OPD clients newly identified as HIV-positive and antiretroviral therapy (ART) initiation. Costs and cost-effectiveness will be evaluated. Nested studies will determine the acceptability of facility-based HIVST among OPD clients and health care providers, the presence of adverse events, such as coercion to test or unwanted status disclosure, and a process evaluation to determine feasibility and scale-up of facility-based HIVST for the future. DISCUSSION: This study protocol tests whether facility-based HIVST can positively contribute to HIV-testing among OPD clients in resource-limited settings. This will be one of the first studies to test the integration of HIVST into facility-based, primary health services in sub-Saharan Africa.

trial registrationClinicalTrials.gov, ID: NCT03271307 . Registered on 31 August 2017. Pan African Clinical Trials: PACTR201711002697316 . Registered on 1 November 2017.

Indexed as

Ambulatory CareDelivery of Health Care, IntegratedDeveloping CountriesDiagnostic Self EvaluationHealth ResourcesReagent Kits, DiagnosticCost-Benefit AnalysisHealth Care CostsHIV InfectionsHumansMalawiMulticenter Studies as TopicPatient Acceptance of Health CarePredictive Value of TestsRandomized Controlled Trials as TopicReagent Kits, DiagnosticCost-effectivenessHIVHIV self-testingHIV testingRandomized control trialSub-Saharan Africa

Identifiers

PMID30223874
PMCPMC6142354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.